Search Results

You are looking at 1 - 10 of 44 items for :

  • "lobectomy" x
Clear All
Full access

Paul J. Speicher, Lin Gu, Xiaofei Wang, Matthew G. Hartwig, Thomas A. D'Amico and Mark F. Berry

, whereas a single-institution retrospective study of 119 patients who underwent lobectomy for stage IB NSCLC found that adjuvant platinum-based chemotherapy was associated with improved survival. 3 , 6 , 9 – 11 The CALGB 9633 trial demonstrated an early

Full access

Thomas A. D'Amico

-stage non–small cell lung cancer (NSCLC), lobectomy with mediastinal lymph node dissection is considered the optimal treatment. 2 Segmentectomy, anatomic sublobar resection of one or more bronchopulmonary segments, has a role in the management of some

Full access

Jacob Klapper and Thomas A. D’Amico

Background Minimally invasive thoracoscopic surgery is defined by the reliance on video technology and the avoidance of rib spreading. Since lobectomy using video-assisted thoracoscopic surgery (VATS) was first reported, 1 – 3 the application

Full access

Aaron M. Cheng and Douglas E. Wood

Surgery has remained the primary therapy in the treatment of early-stage lung cancer. Traditionally, this has meant anatomic resection by open thoracotomy. Since the initial report of video-assisted thoracoscopic surgical (VATS) lobectomy

Full access

Ya-Fu Cheng, Wei-Heng Hung, Heng-Chung Chen, Ching-Yuan Cheng, Ching-Hsiung Lin, Sheng-Hao Lin and Bing-Yen Wang

independent cohort of cases from 2016 was obtained for cutoff validation. Patients with cT1–3N2M0 lung cancer who underwent surgical resection (pneumonectomy, lobectomy/bilobectomy, or sublobectomy) or C/T, with or without RT, were eligible. Patients were

Full access

Steven G. Waguespack and Gary Francis

, thyroglobulin antibody; TSH, thyroid-stimulating hormone; US, ultrasound. * Rare cases where lobectomy may suffice. † Macroscopic lesions are considered to be larger than 1 cm. ‡ Low-risk: primary tumor does not grossly invade the trachea, recurrent

Full access

Kevin Yauy, Marion Imbert-Bouteille, Virginie Bubien, Clothilde Lindet-Bourgeois, Gauthier Rathat, Helene Perrochia, Gaëtan MacGrogan, Michel Longy, Didier Bessis, Julie Tinat, Stéphanie Baert-Desurmont, Maud Blanluet, Pierre Vande Perre, Karen Baudry, Pascal Pujol and Carole Corsini

-needle nodule puncture resulted in a diagnosis of follicular thyroid neoplasia (classified as Bethesda category IV). A total thyroid resection was recommended instead of thyroid lobectomy because of the PTEN mutation. In addition, a microvesicular adenoma and

Full access

Donglai Chen, Chang Chen, Junmiao Wen and Yongbing Chen

tended to provide better 5-year overall survival than surgery alone or concurrent chemoradiotherapy, in which lobectomy was considered as the optimal types of resection. However, we have some concerns. First, as shown in Figure 2 and 3, there are

Full access

Vivek Verma

results from 2 phase II trials, 11 , 12 arguably the strongest data to date comes from a recent pooled analysis of the STARS and ROSEL trials. 13 The number of patients was relatively small (n=31 for SABR; n=27 for lobectomy), but after a follow-up of 40

Full access

David S. Ettinger

. 6 Data show that VATS lobectomy decreases morbidity (e.g., decreased postoperative pain, shorter chest tube duration, shorter length of stay in the hospital, preservation of pulmonary function, shorter recovery time) compared with routine